The abstract describes nuclear PKM2 as a co-transcriptional activator and protein kinase that programs genes involved in glycolysis, lipogenesis, redox homeostasis, and cell cycle progression.
First-pass extracted concept
nuclear PKM2
Candidate: concept label1 source documents6 linked claims
Live refresh every 5sNext refresh in 5s
Aliases
nPKM2, PKM2
Extracted Explainers
What the tool is doing
What problem it solves
What it does not solve
Evidence Snippets
Supporting Sources
Linked Claims
Nuclear PKM2 reinforces the Warburg effect and promotes tumor growth, metastasis, and resistance to stress.
Nuclear PKM2 acts as a co-transcriptional activator and protein kinase.
Nuclear PKM2 can be considered the oncogenic component of PKM2.
Nuclear PKM2 is a promising target for precision cancer therapy.
Emerging therapeutic strategies target nuclear PKM2 using small-molecule modulators that stabilize its cytosolic tetrameric form or disrupt its nuclear functions.
Nuclear PKM2 orchestrates transcriptional programs involving glycolysis, lipogenesis, redox homeostasis, and cell cycle progression.